Prosecution Insights
Last updated: April 19, 2026

Examiner: NG, HENRY

Tech Center 3700 • Art Units: 3741

This examiner grants 63% of resolved cases

Performance Statistics

63.1%
Allow Rate
-6.9% vs TC avg
248
Total Applications
+57.9%
Interview Lift
1000
Avg Prosecution Days
Based on 222 resolved cases, 2023–2026

Rejection Statute Breakdown

0.5%
§101 Eligibility
21.6%
§102 Novelty
53.9%
§103 Obviousness
19.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19075310 CONVECTION COOLING AT LOW EFFUSION DENSITY REGION OF COMBUSTOR PANEL Final Rejection RTX Corporation
19060427 SYSTEMS AND METHODS OF DUAL-SPOOL POWER MANAGEMENT Final Rejection RTX Corporation
18770803 CRYO-ASSISTED BOTTOMING CYCLE HEAT SOURCE SEQUENCING Non-Final OA RTX CORPORATION
19278296 GAS TURBINE ENGINE Non-Final OA ROLLS-ROYCE plc
19229076 ENGINE CORE SIZE Final Rejection ROLLS-ROYCE plc
18892741 Engine Core Size Final Rejection ROLLS-ROYCE PLC
18753370 ACTUATED GAS TURBINE ENGINE SYSTEMS Final Rejection ROLLS-ROYCE PLC
18190191 SLOTTED TUBING SECURITY PLATFORM Non-Final OA Alcon Inc.
18303496 INTEGRATED SUBCUTANEOUS SENSOR AND INFUSION DEVICE, SYSTEM AND METHOD Non-Final OA Medtronic MiniMed, Inc.
18123843 Untethered Catheter Containment System and Method Non-Final OA Bard Access Systems, Inc.
17619777 DEPOLLUTED TURBOMACHINE TEST BENCH Final Rejection SAFRAN AERO BOOSTERS
18224938 TURBINE ENGINE VANE ARRAY STRUCTURE WITH AIR PARTICLE SEPARATOR Final Rejection Raytheon Technologies Corporation
18086755 ELECTRICALLY BOOSTED TURBINE COOLING AIR Non-Final OA Raytheon Technologies Corporation
18296443 AUTONOMOUS DOSE DETERMINATION FOR PEN DELIVERY OF MEDICAMENT Non-Final OA Beta Bionics, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month